{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:41:24Z","timestamp":1776238884601,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With rising cancer survival rates and an increasing number of cancer survivors, the sustainability of secondary care follow-up care is under pressure. Transferring certain follow-up tasks to primary care is suggested as a potential solution, but there is no consensus on the optimal strategy for this.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To identify preferences of primary and secondary healthcare providers regarding the transfer of follow-up care for breast, colorectal, and prostate cancer, using a discrete choice experiment (DCE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A DCE was conducted among 153 primary and secondary healthcare professionals in the Netherlands. Attributes related to patient and follow-up characteristics included: type of cancer, age, time post-treatment, any protocolled care for comorbidities, recurrence risk, and types of check-up protocols. A conditional logit model and latent class analysis were used to assess preferences and identify subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Healthcare providers favored the transfer of follow-up care to primary care for prostate cancer patients. Across all cancer types, preferences for substitution were greater in patients aged above 75\u00a0years, longer post-treatment, a low recurrence risk, and who were already enrolled in protocolized chronic care. Transfer of basic check-up care was preferred, while extensive check-up was negatively valued, especially by GPs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Future follow-up should focus on patient groups and tasks for which consensus exists that primary care involvement is feasible and appropriate, forming the basis for sustainable, collaborative, and patient-centered models of care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-026-10538-9","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T02:43:38Z","timestamp":1773542618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferences of healthcare providers regarding future follow-up care for breast, prostate, and colorectal cancer: A discrete choice experiment"],"prefix":"10.1007","volume":"34","author":[{"given":"Geertje B.","family":"Liemburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariken E.","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jako S.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette J.","family":"Berendsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjolein Y.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolien P.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke C.","family":"Korevaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan","family":"Brandenbarg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"issue":"4","key":"10538_CR1","first-page":"308","volume":"75","author":"NS Wagle","year":"2025","unstructured":"Wagle NS, Nogueira L, Devasia TP, Mariotto AB, Yabroff KR, Islami F et al (2025) Cancer treatment and survivorship statistics, 2025. CA Cancer J Clin 75(4):308\u2013340","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10538_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10538_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A et al (2025Apr 1) The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer 156(7):1336\u20131346","journal-title":"Int J Cancer"},{"key":"10538_CR4","unstructured":"Netherlands Cancer Registry (NCR), Netherlands Comprehensive Cancer Organisation (IKNL). Netherlands Cancer Registry: population-based cancer data. Available from: https:\/\/www.iknl.nl\/en\/ncr. Accessed Jan 2024"},{"issue":"8","key":"10538_CR5","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","volume":"30","author":"F Cardoso","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT et al (2019Aug 1) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol 30(8):1194\u20131220","journal-title":"Ann Oncol"},{"issue":"Suppl 6","key":"10538_CR6","doi-asserted-by":"publisher","first-page":"vi64","DOI":"10.1093\/annonc\/mdt354","volume":"24","author":"R Labianca","year":"2013","unstructured":"Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandal\u00e0 M, Cervantes A et al (2013) Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):vi64-72","journal-title":"Ann Oncol"},{"issue":"9","key":"10538_CR7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","volume":"31","author":"C Parker","year":"2020","unstructured":"Parker C, Castro E, Fizazi K, Heidenreich A, Ost P, Procopio G et al (2020) Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31(9):1119\u20131134","journal-title":"Ann Oncol"},{"key":"10538_CR8","unstructured":"Dutch Association of Medical Specialists (Federatie Medisch Specialisten). Richtlijn Colorectaal Carcinoom [Colorectal Cancer Guidelines]. Published September 2025. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/colorectaal_carcinoom_crc\/startpagina_-_colorectaal_carcinoom.html. Accessed Sept 2025"},{"key":"10538_CR9","unstructured":"Dutch Association of Medical Specialists (Federatie Medisch Specialisten). Richtlijn Borstkanker [Breast Cancer Guidelines]. Published July 2025. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/borstkanker\/startpagina_-_borstkanker.html. Accessed Sept 2025"},{"issue":"2","key":"10538_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1200\/JOP.0723601","volume":"3","author":"C Erikson","year":"2007","unstructured":"Erikson C, Salsberg E, Forte G, Bruinooge S, Goldstein M (2007) Future supply and demand for oncologists\u202f: challenges to assuring access to oncology services. J Oncol Pract 3(2):79\u201386","journal-title":"J Oncol Pract"},{"issue":"4","key":"10538_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11764-012-0232-z","volume":"6","author":"D Howell","year":"2012","unstructured":"Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M et al (2012) Models of care for post-treatment follow-up of adult cancer survivors: a systematic review and quality appraisal of the evidence. J Cancer Surviv 6(4):359\u2013371","journal-title":"J Cancer Surviv"},{"issue":"1","key":"10538_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11764-020-00911-w","volume":"15","author":"JAM Vos","year":"2021","unstructured":"Vos JAM, Wieldraaijer T, van Weert HCPM, van Asselt KM (2021) Survivorship care for cancer patients in primary versus secondary care: a systematic review. J Cancer Surviv 15(1):66\u201376","journal-title":"J Cancer Surviv"},{"issue":"10334","key":"10538_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(22)00306-3","volume":"399","author":"M Jefford","year":"2022","unstructured":"Jefford M, Howell D, Li Q, Lisy K, Maher J, Alfano CM et al (2022Apr 16) Improved models of care for cancer survivors. Lancet 399(10334):1551\u20131560","journal-title":"Lancet"},{"key":"10538_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2024.108139","volume":"122","author":"GB Liemburg","year":"2024","unstructured":"Liemburg GB, Korevaar JC, Logtenberg M, Berendsen AJ, Berger MY, Brandenbarg D (2024) Cancer follow-up in primary care after treatment with curative intent: views of patients with breast and colorectal cancer. Patient Educ Couns 122:108139","journal-title":"Patient Educ Couns"},{"issue":"721","key":"10538_CR15","doi-asserted-by":"publisher","first-page":"e592","DOI":"10.3399\/BJGP.2021.0519","volume":"72","author":"GB Liemburg","year":"2022","unstructured":"Liemburg GB, Korevaar JC, van Zomeren WT, Berendsen AJ, Brandenbarg D (2022Jul 28) Follow-up of curatively treated cancer in primary care: a qualitative study of the views of Dutch GPs. Br J Gen Pract 72(721):e592\u2013e600","journal-title":"Br J Gen Pract"},{"key":"10538_CR16","doi-asserted-by":"crossref","unstructured":"Liemburg GB, Korevaar JC, Berendsen AJ, Berger MY, Brandenbarg D (2025) Organizing substitution of oncological follow-up to primary care: perspectives from secondary care providers. J Cancer Surviv","DOI":"10.1007\/s11764-025-01764-x"},{"issue":"1","key":"10538_CR17","first-page":"55","volume":"2","author":"M Ryan","year":"2003","unstructured":"Ryan M, Gerard K (2003) Using discrete choice experiments to value health care programmes: current practice and future research reflections. Appl Health Econ Health Policy 2(1):55\u201364","journal-title":"Appl Health Econ Health Policy"},{"issue":"4","key":"10538_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"JFP Bridges","year":"2011","unstructured":"Bridges JFP, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA et al (2011) Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health 14(4):403\u2013413","journal-title":"Value Health"},{"issue":"4","key":"10538_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1586\/14737167.2.4.319","volume":"2","author":"R Viney","year":"2002","unstructured":"Viney R, Lancsar E, Louviere J (2002) Discrete choice experiments to measure consumer preferences for health and healthcare. Expert Rev Pharmacoecon Outcomes Res 2(4):319\u2013326","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10538_CR20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1086\/259131","volume":"74","author":"KJ Lancaster","year":"1966","unstructured":"Lancaster KJ (1966) A new approach to consumer theory. J Polit Econ 74:132\u2013157","journal-title":"J Polit Econ"},{"key":"10538_CR21","doi-asserted-by":"crossref","unstructured":"Heins M, Schellevis F, Schotman M, van Bezooijen B, Tchaoussoglou I, van der Waart M et al (2018 Dec 12) Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study. BJGP Open 2(4):bjgpopen18X101616","DOI":"10.3399\/bjgpopen18X101616"},{"issue":"5","key":"10538_CR22","volume":"30","author":"GB Liemburg","year":"2021","unstructured":"Liemburg GB, Brandenbarg D, Berger MY, Duijts SFA, Holtman GA, de Bock GH et al (2021) Diagnostic accuracy of follow-up tests for detecting colorectal cancer recurrences in primary care: a systematic review and meta-analysis. Eur J Cancer Care (Engl) 30(5):e13432","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"5","key":"10538_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","volume":"8","author":"EW de Bekker-Grob","year":"2015","unstructured":"de Bekker-Grob EW, Donkers B, Jonker MF, Stolk EA (2015) Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Patient 8(5):373\u2013384","journal-title":"Patient"},{"key":"10538_CR24","unstructured":"Johnson RM, Omre BK (1996) How many questions should you ask in choice-based conjoint studies?. Sawtooth Software Res Paper Ser 1\u201310"},{"key":"10538_CR25","unstructured":"Orme BK (2009) Getting started with conjoint analysis: strategies for product design and pricing research, 2nd edn. Research Publishers LLC, Lincoln"},{"issue":"13","key":"10538_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133166","volume":"28","author":"BM Wollersheim","year":"2022","unstructured":"Wollersheim BM, van Asselt KM, Pos FJ, Akdemir E, Crouse S, van der Poel HG et al (2022) Specialist versus primary care prostate cancer follow-up: a process evaluation of a randomized controlled trial. Cancers (Basel) 28(13):3166. https:\/\/doi.org\/10.3390\/cancers14133166","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10538_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/OP-24-00491","volume":"21","author":"JAM Vos","year":"2025","unstructured":"Vos JAM, Wollersheim BM, van Weert HCPM, van de Poll-Franse LV, van Asselt KM (2025) General practitioners\u2019 experiences with implementing colon or prostate cancer survivorship care in primary care: a cross-sectional survey nested within two randomized-controlled trials. JCO Oncol Pract 21(6):773\u2013780","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10538_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/02813432.2018.1426141","volume":"36","author":"T Wieldraaijer","year":"2018","unstructured":"Wieldraaijer T, Duineveld LAM, Donkervoort SC, Busschers WB, van Weert HCPM, Wind J (2018) Colorectal cancer patients\u2019 preferences for type of caregiver during survivorship care. Scand J Prim Health Care 36(1):14\u201319","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"10538_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/0284186X.2016.1267398","volume":"56","author":"LJ Huibertse","year":"2017","unstructured":"Huibertse LJ, van Eenbergen M, de Rooij BH, Bastiaens MT, Fossion LMCL, de la Fuente RB et al (2017) Cancer survivors\u2019 preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry. Acta Oncol 56(2):278\u2013287","journal-title":"Acta Oncol"},{"issue":"6","key":"10538_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.31128\/AJGP-05-20-5417","volume":"50","author":"E Lynch","year":"2021","unstructured":"Lynch E, McIntosh J, Koczwara B, Crowe J, Emery J (2021) Managing patients receiving new and unfamiliar cancer treatments: a qualitative study of general practitioners\u2019 experience. Aust J Gen Pract 50(6):426\u2013430","journal-title":"Aust J Gen Pract"},{"issue":"3","key":"10538_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/fampra\/cmx105","volume":"35","author":"H Sch\u00fctze","year":"2018","unstructured":"Sch\u00fctze H, Chin M, Weller D, Harris MF (2018May 23) Patient, general practitioner and oncologist views regarding long-term cancer shared care. Fam Pract 35(3):323\u2013329","journal-title":"Fam Pract"},{"issue":"4","key":"10538_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30174","volume":"70","author":"L Nekhlyudov","year":"2023","unstructured":"Nekhlyudov L, Snow C, Knelson LP, Dibble KE, Alfano CM, Partridge AH (2023) Primary care providers\u2019 comfort in caring for cancer survivors: implications for risk-stratified care. Pediatr Blood Cancer 70(4):e30174","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10538_CR33","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s11606-016-3746-7","volume":"31","author":"RA Lawrence","year":"2016","unstructured":"Lawrence RA, McLoone JK, Wakefield CE, Cohn RJ (2016) Primary care physicians\u2019 perspectives of their role in cancer care: a systematic review. J Gen Intern Med 31(10):1222\u20131236","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10538_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jep.13608","volume":"28","author":"C Fern\u00e1ndez-Aguilar","year":"2022","unstructured":"Fern\u00e1ndez-Aguilar C, Mart\u00edn-Mart\u00edn JJ, Minu\u00e9 Lorenzo S, Fern\u00e1ndez Ajuria A (2022) Use of heuristics during the clinical decision process from family care physicians in real conditions. J Eval Clin Pract 28(1):135\u2013141","journal-title":"J Eval Clin Pract"},{"issue":"655","key":"10538_CR35","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3399\/bjgp17X688861","volume":"67","author":"RF Fisher","year":"2017","unstructured":"Fisher RF, Croxson CH, Ashdown HF, Hobbs FR (2017) Gp views on strategies to cope with increasing workload: a qualitative interview study. Br J Gen Pract 67(655):e148\u2013e156","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10538_CR36","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1111\/bjop.12668","volume":"114","author":"C Dawson","year":"2023","unstructured":"Dawson C (2023) Gender differences in optimism, loss aversion and attitudes towards risk. Br J Psychol 114(4):928\u2013944","journal-title":"Br J Psychol"},{"issue":"1","key":"10538_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12913-018-3044-7","volume":"18","author":"A Nebout","year":"2018","unstructured":"Nebout A, Cavillon M, Ventelou B (2018Apr 12) Comparing GPs\u2019 risk attitudes for their own health and for their patients\u2019\u202f: a troubling discrepancy? BMC Health Serv Res 18(1):283\u2013287","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10538_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/bs10010006","volume":"10","author":"N Bogacheva","year":"2019","unstructured":"Bogacheva N, Kornilova T, Pavlova E (2019) Relationships between medical doctors\u2019 personality traits and their professional risk perception. Behav Sci 10(1):6. https:\/\/doi.org\/10.3390\/bs10010006","journal-title":"Behav Sci"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10538-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10538-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:42:00Z","timestamp":1776235320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10538-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10538"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10538-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"25 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the Medical Ethical Committee (METc) of the University Medical Center Groningen, this study was not subjected to the Medical Research Involving Human Subjects Act (WMO).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}